218 related articles for article (PubMed ID: 12843854)
1. [Treatment of familial erythermalgia with the association of lidocaine and mexiletine].
Legroux-Crespel E; Sassolas B; Guillet G; Kupfer I; Dupre D; Misery L
Ann Dermatol Venereol; 2003 Apr; 130(4):429-33. PubMed ID: 12843854
[TBL] [Abstract][Full Text] [Related]
2. Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment.
Nathan A; Rose JB; Guite JW; Hehir D; Milovcich K
Pediatrics; 2005 Apr; 115(4):e504-7. PubMed ID: 15741349
[TBL] [Abstract][Full Text] [Related]
3. [Familial erythermalgia treated with pizotifen].
Guillet MH; Le Noach E; Milochau P; Sassolas B; Guillet G
Ann Dermatol Venereol; 1995; 122(11-12):777-9. PubMed ID: 8729824
[TBL] [Abstract][Full Text] [Related]
4. Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off.
Choi JS; Zhang L; Dib-Hajj SD; Han C; Tyrrell L; Lin Z; Wang X; Yang Y; Waxman SG
Exp Neurol; 2009 Apr; 216(2):383-9. PubMed ID: 19162012
[TBL] [Abstract][Full Text] [Related]
5. The effects of mexiletine on excitability properties of human median motor axons.
Kuwabara S; Misawa S; Tamura N; Kanai K; Hiraga A; Ogawara K; Nakata M; Hattori T
Clin Neurophysiol; 2005 Feb; 116(2):284-9. PubMed ID: 15661106
[TBL] [Abstract][Full Text] [Related]
6. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous lidocaine in the treatment of post treatment neuropathy].
Fukuda H; Kasuda H; Nemoto K; Shimizu R
Masui; 1994 Jun; 43(6):941-3. PubMed ID: 8072160
[TBL] [Abstract][Full Text] [Related]
8. The management of oral mexiletine and intravenous lidocaine to treat chronic painful symmetrical distal diabetic neuropathy.
Ackerman WE; Colclough GW; Juneja MM; Bellinger K
J Ky Med Assoc; 1991 Oct; 89(10):500-1. PubMed ID: 1744511
[TBL] [Abstract][Full Text] [Related]
9. Mexiletine in the treatment of spasmodic torticollis.
Ohara S; Hayashi R; Momoi H; Miki J; Yanagisawa N
Mov Disord; 1998 Nov; 13(6):934-40. PubMed ID: 9827618
[TBL] [Abstract][Full Text] [Related]
10. The cutaneous analgesic effect of class I antiarrhythmic drugs.
Tzeng JI; Cheng KI; Huang KL; Chen YW; Chu KS; Chu CC; Wang JJ
Anesth Analg; 2007 Apr; 104(4):955-8. PubMed ID: 17377113
[TBL] [Abstract][Full Text] [Related]
11. Lidocaine and oral mexiletine block reflex bronchoconstriction in asthmatic subjects.
Zemenick RB
Am J Respir Crit Care Med; 1997 Nov; 156(5):1703-4. PubMed ID: 9372699
[No Abstract] [Full Text] [Related]
12. Mexiletine for refractory chronic daily headache: a report of nine cases.
Marmura MJ; Passero FC; Young WB
Headache; 2008; 48(10):1506-10. PubMed ID: 18793209
[TBL] [Abstract][Full Text] [Related]
13. Lidocaine and mexiletine therapy for erythromelalgia.
Kuhnert SM; Phillips WJ; Davis MD
Arch Dermatol; 1999 Dec; 135(12):1447-9. PubMed ID: 10606048
[No Abstract] [Full Text] [Related]
14. Differential contribution of sodium channel subtypes to action potential generation in unmyelinated human C-type nerve fibers.
Lang PM; Hilmer VB; Grafe P
Anesthesiology; 2007 Sep; 107(3):495-501. PubMed ID: 17721253
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a pilot study.
Nalamachu S; Crockett RS; Mathur D
J Fam Pract; 2006 Mar; 55(3):209-14. PubMed ID: 16510054
[TBL] [Abstract][Full Text] [Related]
16. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.
Michiels JJ; te Morsche RH; Jansen JB; Drenth JP
Arch Neurol; 2005 Oct; 62(10):1587-90. PubMed ID: 16216943
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity of lidocaine combined with mexiletine.
Christie JM; Valdes C; Markowsky SJ
Anesth Analg; 1993 Dec; 77(6):1291-4. PubMed ID: 8250327
[No Abstract] [Full Text] [Related]
18. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
19. A Multi-Centered Case Series Highlighting the Clinical Use and Dosing of Lidocaine and Mexiletine for Refractory Cancer Pain.
Atayee RS; Naidu D; Geiger-Hayes J; Saphire ML; Hausdorff J; Edmonds KP
J Pain Palliat Care Pharmacother; 2020 Jun; 34(2):90-98. PubMed ID: 32091938
[TBL] [Abstract][Full Text] [Related]
20. Oral and local anesthesia in the nonsurgical radiofrequency-energy treatment of stress urinary incontinence.
Lenihan JP; Palacios P; Sotomayor M
J Minim Invasive Gynecol; 2005; 12(5):415-9. PubMed ID: 16213427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
